6993:HKEXBlue Moon Group Holdings Ltd. Analysis
Data as of 2026-09-14 - not real-time
HK$3.61
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Blue Moon Group Holdings Limited trades at HKD 3.61, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 13.3%. With RSI at 53.0 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near HKD 3.21 and resistance around HKD 3.97.
On valuation the read is overvalued — an earnings multiple of 694.2, absent a reliable peer benchmark. Consensus targets land 29.9% below where the shares trade now. Revenue is contracting at 5.1% on a -1.0% profit margin. The 4.83% dividend yield looks stretched against payout coverage.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 29.1%, a beta of 0.29 and a maximum drawdown of 30.9%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against sell longer out, with 6/10 conviction on the long call.
On valuation the read is overvalued — an earnings multiple of 694.2, absent a reliable peer benchmark. Consensus targets land 29.9% below where the shares trade now. Revenue is contracting at 5.1% on a -1.0% profit margin. The 4.83% dividend yield looks stretched against payout coverage.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 29.1%, a beta of 0.29 and a maximum drawdown of 30.9%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against sell longer out, with 6/10 conviction on the long call.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 3.01
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Dividend yield of 4.83% looks stretched against payout coverage
- Trading above the 200-day average of 3.01
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Dividend yield of 4.83% looks stretched against payout coverage
- Negative profit margin of -1.0%
- Analyst targets imply -29.9% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin-1.04%
P/E Ratio694.2
ROE-1.19%
ROA2.31%
Debt/Equity1.17
P/B Ratio3.1
Technical Analysis
TrendBullish
RSI53.0
SupportHK$3.21
ResistanceHK$3.97
MA 20HK$3.61
MA 50HK$3.33
MA 200HK$3.01
MACDBearish
VolumeDecreasing
Fear & Greed Index89.68
Valuation
Target PriceHK$2.53
Upside/Downside-29.92%
GradeOvervalued
TypeBlend
Dividend Yield4.83%
Risk Assessment
Beta0.29
Volatility29.13%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.